RYTM Rhythm Pharmaceuticals, Inc.

Fundamentals / CIK 0001649904 / USD

Rhythm Pharmaceuticals, Inc. reported $280.7M in revenue and a net loss of $193.8M for the trailing twelve months ended September 30, 2026 (up 79.6% year over year), with a 88.2% gross margin and a -66.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RYTM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$214.5M$107.3M$0-$259.8MFY 2016 Revenue: $0FY 2016 Net Income: -$29.07M2016FY 2017 Revenue: $0FY 2017 Net Income: -$33.71M2017FY 2018 Revenue: $0FY 2018 Net Income: -$74.06M2018FY 2019 Revenue: $0FY 2019 Net Income: -$140.7M2019FY 2020 Revenue: $0FY 2020 Net Income: -$134.0M2020FY 2021 Revenue: $3.15MFY 2021 Net Income: -$69.61M2021FY 2022 Revenue: $23.64MFY 2022 Net Income: -$181.1M2022FY 2023 Revenue: $77.43MFY 2023 Net Income: -$184.7M2023FY 2024 Revenue: $130.1MFY 2024 Net Income: -$260.6M2024FY 2025 Revenue: $189.8MFY 2025 Net Income: -$196.5M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $189.8M $130.1M $77.43M $23.64M $3.15M $0 $0 $0 $0 $0
Cost of Revenue $19.49M $13.37M $9.30M $2.13M $599K -- -- -- -- --
Gross Profit $170.3M $116.8M $68.13M $21.50M $2.56M -- -- -- -- --
Research & Development $167.3M $238.0M $135.0M $108.6M $104.1M $90.45M $109.5M $50.34M $22.89M $19.59M
Selling, General & Admin $194.9M $144.3M $117.5M $92.03M $68.49M $46.12M $36.55M $28.08M $9.52M $6.31M
Total Operating Expenses -- -- -- -- -- $136.6M $146.0M $78.42M $32.41M $25.91M
Operating Income -$192.0M -$265.5M -$184.4M -$179.2M -$170.1M -$136.6M -$146.0M -$78.42M -$32.41M -$25.91M
EBITDA -$191.5M -$264.8M -$183.5M -$178.3M -$169.2M -$135.9M -$145.2M -$77.97M -$32.19M -$25.76M
Interest Income -- -- -- -- $447K $2.58M $5.27M $4.35M $566K $33K
Interest Expense $20.58M $20.60M $13.89M $5.20M -- -- -- -- -- --
Income Before Tax -$196.0M -$260.3M -$184.1M -$181.1M -$69.61M -- -- -- -- --
Income Tax Expense $497K $346K $564K -- -- -- -- -- -- --
Net Income -$196.5M -$260.6M -$184.7M -$181.1M -$69.61M -$134.0M -$140.7M -$74.06M -$33.71M -$29.07M
Basic EPS -$3.11 -$4.34 -$3.20 -$3.47 -$1.40 -$3.04 -$3.86 -$2.39 -$2.83 -$2.85
Diluted EPS -$3.11 -$4.34 -$3.20 -$3.47 -$1.40 -$3.04 -$3.86 -$2.39 -$2.83 -$2.85
Basic Shares Outstanding 65.0M 61.0M 57.7M 52.1M 49.6M 44.1M 36.4M 31.0M 13.3M 10.2M
Diluted Shares Outstanding 65.0M 61.0M 57.7M 52.1M 49.6M 44.1M 36.4M 31.0M 13.3M 10.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $92.13M $71.25M $60.11M $57.25M $51.30M $48.50M $32.70M $41.83M
Cost of Revenue $12.17M $8.93M $7.16M $4.80M $5.50M $5.54M $3.65M $3.79M
Gross Profit $79.96M $62.32M $52.95M $52.45M $45.80M $42.96M $29.06M $38.04M
Research & Development $52.48M $43.43M $41.73M $42.03M $46.03M $42.31M $36.97M $41.17M
Selling, General & Admin $66.75M $67.45M $63.59M $57.48M $52.42M $45.95M $39.09M $38.13M
Operating Income -$39.27M -$48.55M -$52.36M -$47.06M -$52.65M -$45.30M -$47.00M -$41.26M
Interest Expense $4.50M $4.54M $4.58M $4.62M $4.74M $5.82M $5.41M $5.45M
Income Before Tax -$40.76M -$48.85M -$55.09M -$47.54M -$52.79M -$46.30M -$49.42M -$43.38M
Income Tax Expense $610K $444K $545K -$31K $111K $337K $80K -$90K
Net Income -$41.37M -$49.30M -$55.64M -$47.51M -$52.90M -$46.63M -$49.50M -$43.29M
Basic EPS -$0.61 -$0.73 -$0.83 -- -$0.82 -$0.75 -$0.81 --
Diluted EPS -$0.61 -$0.73 -$0.83 -- -$0.82 -$0.75 -$0.81 --
Basic Shares Outstanding 69.0M 68.6M 68.0M -- 66.3M 63.7M 63.1M --
Diluted Shares Outstanding 69.0M 68.6M 68.0M -- 66.3M 63.7M 63.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $54.30M $89.14M $60.08M $127.7M $59.25M $100.9M $62.29M $49.54M $34.24M $6.54M
Short-Term Investments $334.6M $231.4M $215.8M $205.6M $235.6M $71.94M $230.2M -- -- --
Cash & Short-Term Investments $388.9M $320.6M $275.8M $333.3M $294.9M $172.8M $292.5M $252.1M $148.1M $10.54M
Accounts Receivable, Net $26.08M $18.51M $14.87M $6.22M $1.02M -- -- -- -- --
Inventory $25.75M $18.74M $8.62M $2.92M $111K -- -- -- -- --
Other Current Assets $9.97M $8.80M $6.67M $7.42M $3.99M $3.05M $3.51M $1.34M $1.06M $216K
Total Current Assets $466.9M $374.2M $308.3M $354.2M $308.4M $181.7M $302.4M $258.7M $150.7M $11.18M
Property, Plant & Equipment, Net $1.10M $632K $1.34M $2.20M $2.81M $3.19M $3.67M $1.12M $840K $930K
Intangible Assets $5.32M $6.17M $7.03M $7.88M $4.66M -- -- -- -- --
Other Non-Current Assets $3.29M $7.33M $15.00M $16.66M -- -- -- -- -- --
Total Non-Current Assets $13.28M $18.07M $24.48M $28.25M $21.14M $5.41M $6.12M $1.52M $1.06M $1.16M
Total Assets $480.2M $392.3M $332.7M $382.5M $329.5M $187.1M $308.5M $260.2M $151.7M $12.34M
Accounts Payable $13.95M $12.33M $4.88M $4.80M $5.74M $4.90M $10.41M $7.64M $2.43M $1.90M
Short-Term Debt $7.30M $1.54M -- -- -- -- -- -- -- --
Deferred Revenue (Current) $194K $1.29M $1.29M $1.43M $7.00M -- -- -- -- --
Other Current Liabilities $0 $37.70M -- -- -- -- -- -- -- --
Total Current Liabilities $105.9M $115.5M $55.20M $39.81M $43.43M $17.99M $24.42M $13.58M $6.72M $4.73M
Long-Term Debt $100.9M $108.3M $106.1M -- -- -- -- -- -- --
Deferred Revenue (Non-Current) -- -- $106.1M $75.81M -- -- -- -- -- --
Total Non-Current Liabilities $104.2M $112.2M $107.8M $78.41M $1.95M $2.55M $3.09M $372K $228K $311K
Total Liabilities $210.2M $227.7M $163.0M $118.2M $45.37M $20.55M $27.50M $13.95M $6.95M $5.04M
Total Debt (incl. Leases) $112.2M $113.7M $107.4M $1.94M $4.50M $5.64M $6.64M $3.64M -- --
Common Stock $67K $61K $59K $56K $50K $44K $44K $34K $27K $10K
Retained Earnings -$1.35B -$1.16B -$894.7M -$710.1M -$528.9M -$459.3M -$325.3M -$184.6M -$110.3M -$76.54M
Accumulated Other Comp. Income -$796K -$39K $134K -$92K -$1.0K $49K -- -- -- --
Total Stockholders' Equity $139.1M $21.73M $169.8M $264.3M $284.2M $166.5M $281.0M $246.3M $144.8M -$32.70M
Total Equity $139.1M $21.73M $169.8M $264.3M $284.2M $166.5M $281.0M $246.3M $144.8M -$32.70M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $39.98M $65.61M $62.14M $54.30M $52.08M $135.6M $106.1M $89.14M
Short-Term Investments $281.0M $265.3M $278.5M $334.6M $364.0M $155.4M $208.4M $231.4M
Cash & Short-Term Investments $320.9M $330.9M $340.6M $388.9M $416.1M $291.0M $314.5M $320.6M
Accounts Receivable, Net $39.12M $40.41M $34.19M $26.08M $33.03M $26.12M $17.82M $18.51M
Inventory $31.19M $30.52M $28.65M $25.75M $22.11M $18.87M $19.32M $18.74M
Other Current Assets -- -- -- $9.97M -- -- -- $8.80M
Total Current Assets $419.4M $426.6M $430.1M $466.9M $494.8M $360.7M $369.3M $374.2M
Property, Plant & Equipment, Net $569K $103K $1.06M $1.10M $237K $297K $462K $632K
Intangible Assets $16.68M $4.89M $5.11M $5.32M $5.53M $5.75M $5.96M $6.17M
Other Non-Current Assets -- -- -- $3.29M -- -- -- $7.33M
Total Non-Current Assets $23.77M $10.70M $12.23M $13.28M $12.07M $12.05M $17.40M $18.07M
Total Assets $443.1M $437.3M $442.3M $480.2M $506.9M $372.7M $386.7M $392.3M
Accounts Payable $10.69M $16.16M $12.30M $13.95M $13.63M $15.98M $11.91M $12.33M
Short-Term Debt $14.75M $12.70M $10.13M $7.30M $5.56M $3.78M $1.59M $1.54M
Deferred Revenue (Current) $0 $0 $48K $194K -- -- -- $1.29M
Other Current Liabilities -- -- -- $0 -- $40.00M $38.78M $37.70M
Total Current Liabilities $150.9M $123.6M $103.2M $105.9M $104.3M $129.5M $111.8M $115.5M
Long-Term Debt $87.92M $93.40M $98.34M $100.9M $103.4M $106.0M $107.9M $108.3M
Total Non-Current Liabilities $90.70M $96.38M $101.5M $104.2M $106.9M $109.7M $111.8M $112.2M
Total Liabilities $241.6M $220.0M $204.7M $210.2M $211.2M $239.2M $223.6M $227.7M
Total Debt (incl. Leases) $106.2M $109.8M $112.3M $112.2M $113.1M $114.0M $113.6M $113.7M
Common Stock $70K $69K $69K $67K $67K $64K $62K $61K
Retained Earnings -$1.50B -$1.46B -$1.41B -$1.35B -$1.30B -$1.25B -$1.20B -$1.16B
Accumulated Other Comp. Income -$1.74M -$912K $444K -$796K -$926K -$2.25M -$51K -$39K
Total Stockholders' Equity $87.97M $103.0M $122.9M $139.1M $148.8M -$11.91M $18.95M $21.73M
Total Equity $87.97M $103.0M $122.9M $139.1M $148.8M -$11.91M $18.95M $21.73M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$196.5M -$260.6M -$184.7M -$181.1M -$69.61M -$134.0M -$140.7M -$74.06M -$33.71M -$25.87M
Depreciation & Amortization $500K $700K $900K $896K $816K $690K $834K $442K $223K $144K
Stock-Based Compensation $66.82M $39.68M $32.55M $19.83M $20.80M $17.45M $11.88M $6.39M $2.28M $1.17M
Change in Receivables -$7.57M -$3.65M -$8.64M -$5.20M -$1.25M -- -- -- -- --
Change in Inventory -$7.47M -$10.12M -$5.71M -$2.81M -$11K -- -- -- -- --
Operating Cash Flow -$115.7M -$113.9M -$136.2M -$173.4M -$146.0M -$122.0M -$122.8M -$62.06M -$29.46M -$23.22M
Capital Expenditure -$953K $0 -$47K -$281K -$434K -$214K -$3.38M -$722K -$133K -$1.06M
Free Cash Flow -$116.6M -$113.9M -$136.2M -$173.7M -$146.4M -$122.2M -$126.1M -$62.78M -$29.59M -$24.28M
Investing Cash Flow -$137.2M -$48.17M -$5.67M $28.03M -$62.16M $158.5M -$27.97M -$87.15M -$110.0M -$5.11M
Common Stock Issued $34.03M $39.15M $48.88M $131.1M $161.7M -- $161.4M $162.9M $125.7M --
Financing Cash Flow $218.0M $191.2M $74.37M $213.8M $166.5M $2.01M $163.5M $164.7M $167.2M --
Net Change in Cash -$34.78M $29.19M -$67.60M $68.43M -$41.68M $38.56M $12.75M $15.48M $27.70M -$28.33M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$41.37M -$49.30M -$55.64M -$47.51M -$52.90M -$46.63M -$49.50M -$43.29M
Stock-Based Compensation $25.02M $26.06M $23.10M $19.27M $18.81M $15.88M $12.86M $10.56M
Change in Receivables $1.29M -$6.22M -$8.11M $6.17M -$6.60M -$7.83M $687K $794K
Change in Inventory -$751K -$2.34M -$3.09M -$4.93M -$2.45M $479K -$575K -$4.85M
Operating Cash Flow -$3.06M -$9.15M -$44.19M -$25.39M -$26.62M -$23.31M -$40.35M -$18.84M
Investing Cash Flow -$16.11M $14.01M $57.05M $30.35M -$246.3M $54.03M $24.81M $21.16M
Common Stock Issued $0 $0 $0 $0 $1.0K $0 $34.03M --
Financing Cash Flow -$6.25M -$1.17M -$5.40M -$2.95M $189.3M -$889K $32.50M $38.33M
Net Change in Cash -$24.95M $3.48M $7.92M $2.07M -$83.36M $29.55M $16.96M $41.62M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 89.7% 89.7% 88.0% 91.0% 81.0% -- -- -- -- --
Operating Margin -101.2% -204.0% -238.1% -757.9% -5391.9% -- -- -- -- --
Net Profit Margin -103.6% -200.3% -238.5% -766.2% -2207.1% -- -- -- -- --
Return on Equity (ROE) -141.3% -1199.3% -108.8% -68.5% -24.5% -80.5% -50.1% -30.1% -23.3% --
Return on Assets (ROA) -40.9% -66.4% -55.5% -47.4% -21.1% -71.6% -45.6% -28.5% -22.2% -235.6%
Current Ratio 4.41x 3.24x 5.58x 8.90x 7.10x 10.10x 12.38x 19.05x 22.42x 2.36x
Quick Ratio 4.16x 3.08x 5.43x 8.83x 7.10x 9.60x 11.98x 18.56x 22.04x 2.23x
Debt to Equity 0.81x 5.23x 0.63x 0.01x 0.02x 0.03x 0.02x 0.01x -- --
Revenue Growth (YoY) +45.8% +68.1% +227.6% +649.5% -- -- -- -- -- --
Gross Profit Growth (YoY) +45.8% +71.4% +216.8% +741.7% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 88.2% 89.0% 89.4% 89.7% 89.4% 89.2% 89.6% 89.7%
Operating Margin -66.7% -83.6% -90.9% -101.2% -106.8% -113.5% -126.1% -204.0%
Net Profit Margin -69.0% -85.6% -93.3% -103.6% -110.3% -117.1% -123.3% -200.2%
Return on Equity (ROE) -220.3% -199.4% -164.9% -141.3% -129.2% -- -890.3% -1199.2%
Return on Assets (ROA) -43.7% -47.0% -45.8% -40.9% -37.9% -49.1% -43.6% -66.4%
Current Ratio 2.78x 3.45x 4.17x 4.41x 4.75x 2.79x 3.30x 3.24x
Quick Ratio 2.57x 3.20x 3.89x 4.16x 4.53x 2.64x 3.13x 3.08x
Debt to Equity 1.21x 1.07x 0.91x 0.81x 0.76x -- 5.99x 5.23x
Revenue Growth (YoY) +79.6% +46.9% +83.8% +36.9% +54.3% +66.8% +25.9% +72.6%
Gross Profit Growth (YoY) +74.6% +45.1% +82.3% +37.9% +55.7% +64.4% +25.5% +81.1%
Source: SEC EDGAR CompanyFacts (CIK 0001649904) · from December 31, 2015 Data through September 30, 2026 · synced Nov 20, 2026, 05:11 UTC · Open in terminal